Skip to content
healthcare.dev

Oxybutynin Chloride

NDC 65162-371, Oxybutynin Chloride, tablet, extended release, from Amneal Pharmaceuticals LLC.

Product NDC
65162-371
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204010
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-371 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE5 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
65162-371-036516203710330 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-371-03)
65162-371-096516203710990 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-371-09)
65162-371-1065162037110100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-371-10)
65162-371-5065162037150500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-371-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/53924eba-1919-4203-9a1e-d57dfdd3b963
  • NADAC price for package 65162037110

    GET /v1/drugs/nadac/65162037110

Use it

Look up 65162-371 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-371 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-371. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.